Dashboard
Manage Tickers

GPCRStructure Therapeutics Inc.

Nasdaq structuretx.com


$ 40.83 $ 0.55 (1.37 %)    

Friday, 13-Sep-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 474.86 $ 2.12 (0.45 %)
DIA $ 414.87 $ 2.97 (0.72 %)
SPY $ 561.82 $ 2.92 (0.52 %)
TLT $ 100.40 $ 0.27 (0.27 %)
GLD $ 238.66 $ 2.35 (0.99 %)
$ 40.84
$ 41.53
$ 40.76 x 118
-- x --
$ 38.28 - $ 42.49
$ 26.61 - $ 75.02
1,055,850
na
6.05B
$ 1.09
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-09-2024 03-31-2024 10-Q
3 03-08-2024 12-31-2023 10-K
4 11-17-2023 09-30-2023 10-Q
5 08-10-2023 06-30-2023 10-Q
6 05-11-2023 03-31-2023 10-Q
7 03-30-2023 12-31-2022 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

cantor-fitzgerald-reiterates-overweight-on-structure-therapeutics-maintains-65-price-target
Cantor Fitzgerald Reiterates Overweight on...
09/09/2024 15:41:55

Cantor Fitzgerald analyst Prakhar Agrawal reiterates Structure Therapeutics (NASDAQ:GPCR) with a Overweight and maintains $6...

cantor-fitzgerald-reiterates-overweight-on-structure-therapeutics-maintains-65-price-target
Cantor Fitzgerald Reiterates Overweight on...
08/19/2024 16:19:24

Cantor Fitzgerald analyst Prakhar Agrawal reiterates Structure Therapeutics (NASDAQ:GPCR) with a Overweight and maintains $6...

cantor-fitzgerald-reiterates-overweight-on-structure-therapeutics-maintains-65-price-target
Cantor Fitzgerald Reiterates Overweight on...
08/15/2024 12:21:59

Cantor Fitzgerald analyst Prakhar Agrawal reiterates Structure Therapeutics (NASDAQ:GPCR) with a Overweight and maintains $6...

jmp-securities-maintains-market-outperform-on-structure-therapeutics-lowers-price-target-to-86
JMP Securities Maintains Market Outperform...
08/09/2024 18:41:35

JMP Securities analyst Jonathan Wolleben maintains Structure Therapeutics (NASDAQ:GPCR) with a Market Outperform and lowers ...

structure-therapeutics-q2-eps-018-beats-023-estimate
Structure Therapeutics Q2 EPS $(0.18) Beat...
08/08/2024 21:20:32

Structure Therapeutics (NASDAQ:GPCR) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate o...

why-aslan-pharmaceuticals-shares-are-trading-lower-by-over-38-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why ASLAN Pharmaceuticals Shares Are Tradi...
07/17/2024 17:28:51

obesity-drugs-focused-stocks-tumble-on-wednesday---whats-going-on-with-eli-lilly-novo-nordisk-viking-therapeutics-structure-therapeutics
Obesity-Drugs Focused Stocks Tumble On Wed...
07/17/2024 14:47:40

Eli Lilly, Novo Nordisk, Viking Therapeutics, and Structure Therapeutics shares are down following Roche's promising CT-996...

asml-reports-q2-results-joins-spirit-airlines-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
ASML Reports Q2 Results, Joins Spirit Airl...
07/17/2024 12:21:19

peering-into-structure-therapeuticss-recent-short-interest
Peering Into Structure Therapeutics's Rece...
07/15/2024 15:15:20

cantor-fitzgerald-reiterates-overweight-on-structure-therapeutics-maintains-65-price-target
Cantor Fitzgerald Reiterates Overweight on...
07/01/2024 13:20:45

Cantor Fitzgerald analyst Prakhar Agrawal reiterates Structure Therapeutics (NASDAQ:GPCR) with a Overweight and maintains $6...

cantor-fitzgerald-reiterates-overweight-on-structure-therapeutics-maintains-65-price-target
Cantor Fitzgerald Reiterates Overweight on...
06/20/2024 16:52:56

Cantor Fitzgerald analyst Prakhar Agrawal reiterates Structure Therapeutics (NASDAQ:GPCR) with a Overweight and maintains $6...

cantor-fitzgerald-reiterates-overweight-on-structure-therapeutics-maintains-65-price-target
Cantor Fitzgerald Reiterates Overweight on...
06/17/2024 17:31:12

Cantor Fitzgerald analyst Prakhar Agrawal reiterates Structure Therapeutics (NASDAQ:GPCR) with a Overweight and maintains $6...

bmo-capital-maintains-outperform-on-structure-therapeutics-raises-price-target-to-100
BMO Capital Maintains Outperform on Struct...
06/07/2024 14:38:01

BMO Capital analyst Evan David Seigerman maintains Structure Therapeutics (NASDAQ:GPCR) with a Outperform and raises the pri...

reported-earlier-structure-therapeutics-prices-upsized-476m-public-offering-9066972-american-depositary-shares-at-5250ads
Reported Earlier, Structure Therapeutics P...
06/06/2024 06:20:27

Structure Therapeutics Inc. (NASDAQ:GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecu...

structure-therapeutics-files-registration-statement-for-proposed-public-offering-of-8m-adss
Structure Therapeutics Files Registration ...
06/03/2024 20:10:31

structure-therapeutics-obesity-candidate-is-very-competitive-to-eli-lillys-orforglipron-analyst-says
Structure Therapeutics Obesity Candidate I...
06/03/2024 19:14:17

Structure Therapeutics reports positive 12-week Phase 2a obesity study results for GSBR-1290, showing a 6.2% weight loss. Canto...

why-science-applications-international-shares-are-trading-lower-by-11-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Science Applications International Sha...
06/03/2024 17:56:53

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
06/03/2024 17:35:22

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
06/03/2024 16:31:06

obesity-data-from-structure-therapeutics-shows-potential-for-weight-loss-drug-candidate
Obesity Data From Structure Therapeutics S...
06/03/2024 15:11:35

Structure Therapeutics announces Phase 2a results for GSBR-1290, showing significant weight loss in obesity study.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION